An interventional study of Experimental: Inductive Therapeutic Exercise (ETI) and Control: Sham Inductive Therapeutic Exercise (sham-ETI) in Multiple Sclerosis, sponsored by Fundación San Juan De Dios. Not yet recruiting at 2 sites in Spain. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-02.
Sponsored by Fundación San Juan De Dios · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 230 studies in Multiple Sclerosis with a site in Spain — 35 open to participants now, 56 under way, 14 of them phase 3. Multiple Sclerosis · Spain.
Among the 230 studies in Multiple Sclerosis with a site in Spain, this one is the 158th largest by planned enrollment of the 202 interventional ones that give a count, is the only one that started in 2027, is one of 68 with no phase, reaches primary completion later than 43 of the 55 other live ones, and was the 230th registered.
3,273 studies on the registry are indexed under Multiple Sclerosis; 665 are open to participants now.
Browse Multiple Sclerosis studies →35 of the 230 studies in Multiple Sclerosis with a site in Spain are open now. Recruiting first, the newest first:
Clarity Health Technologies, Inc · Sites in Spain
Ages 18–65
Sanofi · Sites in Spain, United States, Belgium and 4 more countries
Ages 18–60
Novartis Pharmaceuticals · Sites in Spain, United States, Argentina and 33 more countries
Ages 18–65
Hasselt University · Sites in Spain, Belgium, Italy
Ages 18–65 · Healthy volunteers
Hoffmann-La Roche · Sites in Spain, Argentina, Brazil and 4 more countries
Ages 10–17
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 434 Multiple Sclerosis studies recruiting now, 164 (38%) set no upper age limit and 214 (49%) stop at 75 or younger; 40 take children under 18; 95 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
230 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 13 · Phase 2 47 · Phase 3 65 · Phase 4 17
First in 2002; this study’s year is marked. 1 started in 2027.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 30 is below the median of 50 across 2,208 interventional studies indexed under Multiple Sclerosis.
Median enrollment 137 across the 202 interventional studies, 360 across the 28 observational. Of the 163 that completed or were terminated, 80 (49%) have results posted.
This tab as a report to print or save as PDF → With an account.
142 of 230 have an industry lead sponsor. The 10 most frequent:
This is the only study on the registry with Fundación San Juan De Dios as lead sponsor.
Fundación San Juan De Dios has 1 study filed under Multiple Sclerosis — fewer than ten, so there is no comparison to draw.
13 of the studies in Multiple Sclerosis with a site in Spain that are under way reach primary completion within a year, 2 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06141473Phase 3SanofiEfficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis | 2027-05-06 |
| NCT07325292Phase 3SanofiNon-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis | 2027-07-15 |
| NCT07735325University of SalamancaEffects of Sensorimotor Insoles on Stability and Gait in Patients With Multiple Sclerosis. | 2026-12 |
| NCT07152145Parc de Salut MarPilot Study of tSCS for Improving Upper Limb Function in People With Multiple Sclerosis | 2026-12 |
| NCT06968676Universidad Rey Juan CarlosMixed Reality for Upper Limb Rehabilitation in People With Multiple Sclerosis (VIRTUALDOMUS) | 2026-12-31 |
Add all 13 to your calendar (.ics) → With an account.
Among the 230 studies in Multiple Sclerosis with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
ETOTUR is a research project comprising two complementary stages. The first is an observational study in approximately 50 healthy adults to develop and validate a mobile tool for quantitative assessment of muscle tone using the pendulum test. Measurements obtained with the mobile tool will be compared with laboratory reference systems, and preliminary reference values will be established.
The second stage, which is the focus of this clinical trial registration, is a pilot controlled study involving approximately 30 adults with multiple sclerosis and altered muscle tone and standing postural control. Participants will receive either Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") or Sham Inductive Therapeutic Exercise (sham-ETI), a simulated intervention, with one individual session of approximately 40 minutes per week for 8 weeks.
ETI combines specific active movements and breathing patterns intended to elicit involuntary neuromuscular responses in other body regions. Sham-ETI uses similar movements while omitting the principal movement and breathing components intended to produce induction.
Participants will be assigned using a nonrandom sequential balancing procedure based on relevant baseline characteristics. Outcome assessment will be performed by a physiotherapist blinded to group allocation.
Outcomes will be assessed at baseline, immediately after the 8-week intervention, and approximately one month later. The main outcomes are lower-limb muscle tone assessed using the pendulum test, standing postural control measured with a pressure platform, and health-related quality of life assessed with the Multiple Sclerosis Quality of Life-54 questionnaire (MSQoL-54). Adherence, tolerability, and intervention-related clinical incidents will also be recorded.
The study will explore whether changes following ETI differ from those observed after sham-ETI and will provide preliminary information to support the design of subsequent confirmatory research.
Scientific rationale.
ETOTUR combines the development of an accessible biomechanical assessment tool with an exploratory investigation of Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") in multiple sclerosis. The project addresses two related research needs: obtaining reproducible quantitative measurements of limb pendular behavior and investigating whether an intervention intended to elicit involuntary neuromuscular responses can influence muscle tone, postural control, and health-related quality of life.
The rationale for the measurement component is to complement clinical assessment with instrumented recordings that can be obtained using portable technology. The pendulum test characterizes the movement of a relaxed limb after release, including its initial excursion and subsequent oscillations. ETOTUR will investigate whether a mobile tool can capture these features consistently and with sufficient agreement with laboratory reference systems to support its intended research use.
The therapeutic component investigates ETI as an approach combining specific active movements, positioning, and breathing patterns to elicit neuromuscular responses beyond the body region performing the voluntary movement. The working hypothesis is that these responses may influence tonic and postural regulation. This proposed mechanism provides the rationale for the intervention but is not considered established, and the clinical study is not designed to demonstrate the underlying neurophysiological mechanism directly.
Relationship between the two studies.
The project comprises two sequential studies with distinct populations and objectives. Study 1 is an observational, cross-sectional measurement-validation study in healthy adults. Study 2 is a pilot, nonrandomized, controlled intervention study in adults with multiple sclerosis.
The methodological study will inform the subsequent clinical use of the measurement tool. The healthy participants will provide measurement-validation data and preliminary reference values; they will not constitute a treatment comparison group for participants with multiple sclerosis. Analyses will be conducted separately for each study.
The clinical intervention study is the focus of this trial registration. The preparatory validation study is described here to explain the development of the assessment approach and its role within the wider ETOTUR project.
Study 1: development and measurement validation.
The first study will develop and evaluate a mobile assessment system for upper- and lower-limb pendulum testing, incorporating portable inertial sensing. Measurements will be compared with laboratory reference recordings obtained using three-dimensional optical motion capture and high-precision triaxial accelerometry, as appropriate to the measurement being evaluated.
Standardized positioning, calibration, synchronization, and limb-release procedures will be used to reduce avoidable variation. Repeated recordings will allow assessment of measurement consistency under the study conditions.
The analysis will distinguish reliability from agreement between systems. Intraclass correlation coefficients will characterize reliability, while agreement analyses, including Bland-Altman methods, will examine systematic differences and the dispersion of differences between the mobile tool and the reference systems. Correlation analyses will provide complementary information about associations between measurements.
The study will also describe the distribution of pendulum-test measurements in the healthy sample. Demographic and anthropometric characteristics will be considered when exploring variation in these measurements. The resulting reference values will be regarded as preliminary and specific to the population and procedures studied.
Validation in healthy adults will provide initial evidence about measurement performance. It will not, by itself, establish diagnostic accuracy for neurological disorders or demonstrate that all measurement properties are preserved in people with abnormal muscle tone. These limits will be considered when interpreting the subsequent clinical findings.
Study 2: exploratory clinical evaluation.
The second study will investigate whether changes following ETI differ from those following a simulated intervention. The sham comparison is intended to account partly for therapist attention, interpersonal interaction, and expectations associated with receiving treatment.
The intervention is individualized within a standardized framework, with maneuver selection informed by the participant's initial postural assessment. The therapeutic rationale involves eliciting responses in the lower limbs through maneuvers performed in another limb, supported by the breathing pattern specified for ETI. The sham intervention preserves external similarities while omitting the principal components intended to produce induction.
Group assignment will use a sequential balancing procedure that considers relevant baseline characteristics. This approach seeks to improve initial comparability but does not constitute randomization or eliminate the possibility of selection bias and residual confounding.
To reduce variation related to treatment delivery, the treating physiotherapists will follow agreed protocols and each will provide interventions in both groups. Outcome assessment will be performed by a physiotherapist who is not involved in intervention delivery and is unaware of group assignment. Treating physiotherapists cannot be blinded to the procedures they deliver.
Interpretation and analytical approach.
The clinical analysis will examine changes over time and differences in change between groups. Longitudinal analyses will consider intervention group and assessment time, with methods selected according to the characteristics of the data and the assumptions of the statistical models. Effect sizes will complement significance testing to characterize the magnitude of observed differences.
Exploratory analyses will examine whether the neuromuscular responses recorded during treatment are associated with changes in biomechanical, postural, or patient-reported outcomes. Such associations will be interpreted as hypothesis-generating and will not establish a causal mechanism.
Session completion, perceived effort, and recorded clinical incidents will inform the assessment of feasibility and tolerability. These findings will help determine whether the intervention and assessment procedures are suitable for a larger study and which aspects require refinement.
Given the pilot sample, nonrandom allocation, and short follow-up period, the clinical findings will be interpreted as preliminary. The project is intended to provide initial measurement evidence, estimates of possible treatment effects, and practical information for planning subsequent confirmatory research.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants will receive one individual session of Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") per week for 8 weeks, with each session lasting approximately 40 minutes. Trained physiotherapists will deliver standardized maneuvers selected according to the participant's initial postural assessment. The protocol combines specific active movements with slow, deep breathing emphasizing expiration, at approximately 5-6 breaths per minute. It includes an upper-limb maneuver intended to elicit involuntary neuromuscular responses in the lower limbs and a lower-limb maneuver intended to elicit responses in the opposite lower limb. Both maneuvers will be performed bilaterally. Perceived effort, induced responses, and clinical incidents will be recorded. Maneuvers will be stopped in the event of excessive fatigue, intense pain, or inability to control the induced responses.
Other: Experimental: Inductive Therapeutic Exercise (ETI)
Participants will receive one individual session of Sham Inductive Therapeutic Exercise (sham-ETI), a simulated intervention, per week for 8 weeks, with each session lasting approximately 40 minutes. Trained physiotherapists will deliver movements that resemble those used in the experimental arm, without reaching the movement range intended to trigger involuntary neuromuscular responses and with greater manual support from the therapist. The specific breathing pattern used to facilitate induction in the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") arm will not be applied. This comparison is intended to account partly for therapist attention, interaction, and participant expectations. Perceived effort and clinical incidents will be recorded, and the same criteria for stopping maneuvers will apply as in the experimental arm.
Other: Control: Sham Inductive Therapeutic Exercise (sham-ETI)
Physiotherapist-supervised exercise combining specific active limb movements with slow, deep breathing emphasizing expiration (approximately 5-6 breaths per minute), intended to elicit involuntary neuromuscular responses in other body regions. An upper-limb maneuver targets responses in the lower limbs, and a lower-limb maneuver targets responses in the opposite lower limb; both are performed bilaterally. Upper-limb maneuver selection follows the initial postural assessment: shoulder abduction with internal rotation for predominant thoracolumbar lateral flexion, or shoulder flexion with external rotation for a predominant rotational pattern. Treatment comprises eight weekly individual sessions of approximately 40 minutes. Maneuvers are stopped for excessive fatigue, intense pain, or inability to control induced responses.
Physiotherapist-supervised simulated exercise resembling the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") maneuvers but performed without reaching the movement range intended to trigger involuntary neuromuscular responses. The therapist provides greater manual support, and the specific slow breathing pattern emphasizing expiration used in ETI is not applied. The intervention comprises eight weekly individual sessions of approximately 40 minutes, matching the experimental intervention in session frequency, duration, and individual therapist contact. The same criteria for stopping maneuvers apply as in the ETI intervention.
Muscle tone: change in lower-limb pendulum test first swing excursion
Change from baseline in first swing excursion during the lower-limb pendulum test, assessed using the mobile measurement tool developed and validated in the preparatory study. First swing excursion is the angular difference between the initial release position and the first reversal point of the pendular movement, expressed in degrees. This parameter characterizes the initial swing of the relaxed lower leg and contributes to the biomechanical assessment of muscle tone. Changes at postintervention and follow-up assessments will be compared between the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") and Sham Inductive Therapeutic Exercise (sham-ETI) groups.
Time frame: Baseline, immediately after the 8-week intervention, and approximately one month after intervention completion (approximately week 12).
Muscle tone: change in lower-limb pendulum test relaxation index
Change from baseline in the relaxation index (RI) derived from the lower-limb pendulum test using the mobile measurement tool developed and validated in the preparatory study. RI is calculated as (initial angle - first reversal angle) / (initial angle - resting angle). The initial angle is the limb position at release, the first reversal angle is the position at the end of the first swing, and the resting angle is the final equilibrium position after oscillations cease. RI is dimensionless. Changes at postintervention and follow-up assessments will be compared between the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") and Sham Inductive Therapeutic Exercise (sham-ETI) groups.
Time frame: Baseline, immediately after the 8-week intervention, and approximately one month after intervention completion (approximately week 12).
Muscle tone: change in lower-limb pendulum test damping ratio
Change from baseline in the damping ratio derived from the lower-limb pendulum test, assessed using the mobile measurement tool developed and validated in the preparatory study. This dimensionless parameter characterizes the damping of limb oscillations following release and contributes to the biomechanical assessment of muscle tone. Changes at postintervention and follow-up assessments will be compared between the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") and Sham Inductive Therapeutic Exercise (sham-ETI) groups.
Time frame: Baseline, immediately after the 8-week intervention, and approximately one month after intervention completion (approximately week 12).
Muscle tone: change in lower-limb pendulum test logarithmic decrement
Change from baseline in the logarithmic decrement derived from the lower-limb pendulum test, assessed using the mobile measurement tool developed and validated in the preparatory study. This dimensionless parameter quantifies the progressive reduction in oscillation amplitude using logarithmic ratios of successive peak amplitudes. Changes at postintervention and follow-up assessments will be compared between the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") and Sham Inductive Therapeutic Exercise (sham-ETI) groups.
Time frame: Baseline, immediately after the 8-week intervention, and approximately one month after intervention completion (approximately week 12).
Muscle tone: change in lower-limb pendulum test oscillation duration
Change from baseline in the total duration of oscillations during the lower-limb pendulum test, assessed using the mobile measurement tool developed and validated in the preparatory study. Duration is measured in seconds from limb release until the oscillations cease. Changes at postintervention and follow-up assessments will be compared between the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") and Sham Inductive Therapeutic Exercise (sham-ETI) groups.
Time frame: Baseline, immediately after the 8-week intervention, and approximately one month after intervention completion (approximately week 12).
Muscle tone: change in lower-limb pendulum test number of oscillations
Change from baseline in the number of oscillations recorded during the lower-limb pendulum test, assessed using the mobile measurement tool developed and validated in the preparatory study. This outcome is expressed as the number of oscillations occurring between limb release and rest. Changes at postintervention and follow-up assessments will be compared between the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") and Sham Inductive Therapeutic Exercise (sham-ETI) groups.
Time frame: Baseline, immediately after the 8-week intervention, and approximately one month after intervention completion (approximately week 12).
Standing postural control: change in center of pressure 95% ellipse area
Change from baseline in the area of the 95% ellipse of center of pressure positions during a standardized quiet-standing assessment using a pressure platform. The ellipse is calculated from the distribution of anteroposterior and mediolateral center of pressure coordinates and characterizes the spatial extent of postural sway. Area is expressed in square millimeters (mm\^2). Changes at postintervention and follow-up assessments will be compared between the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") and Sham Inductive Therapeutic Exercise (sham-ETI) groups.
Time frame: Baseline, immediately after the 8-week intervention, and approximately one month after intervention completion (approximately week 12).
Standing postural control: change in mean center of pressure velocity
Change from baseline in mean center of pressure velocity during a standardized standing balance assessment using a pressure platform. Mean velocity represents the total distance traveled by the center of pressure divided by the recording duration and is expressed in millimeters per second. Changes at postintervention and follow-up assessments will be compared between the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") and Sham Inductive Therapeutic Exercise (sham-ETI) groups.
Time frame: Baseline, immediately after the 8-week intervention, and approximately one month after intervention completion (approximately week 12).
Standing postural control: change in anteroposterior center of pressure RMS displacement
Change from baseline in the root mean square (RMS) of anteroposterior center of pressure displacement during a standardized quiet-standing assessment using a pressure platform. RMS displacement is calculated as the square root of the mean squared deviations of anteroposterior center of pressure coordinates from their mean position during the recording. It characterizes sway amplitude along the anteroposterior axis and is expressed in millimeters. Changes at postintervention and follow-up assessments will be compared between the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") and Sham Inductive Therapeutic Exercise (sham-ETI) groups.
Time frame: Baseline, immediately after the 8-week intervention, and approximately one month after intervention completion (approximately week 12).
Standing postural control: change in mediolateral center of pressure RMS displacement
Change from baseline in the root mean square (RMS) of mediolateral center of pressure displacement during a standardized quiet-standing assessment using a pressure platform. RMS displacement is calculated as the square root of the mean squared deviations of mediolateral center of pressure coordinates from their mean position during the recording. It characterizes sway amplitude along the mediolateral axis and is expressed in millimeters. Changes at postintervention and follow-up assessments will be compared between the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") and Sham Inductive Therapeutic Exercise (sham-ETI) groups.
Time frame: Baseline, immediately after the 8-week intervention, and approximately one month after intervention completion (approximately week 12).
Health-related quality of life: change in MSQoL-54 physical health composite score
Change from baseline in the physical health composite score of the Multiple Sclerosis Quality of Life-54 questionnaire (MSQoL-54), administered using its validated Spanish version. The composite is calculated from a weighted combination of component scale scores according to the instrument's scoring instructions. Scores range from 0 to 100, with higher scores indicating better physical health-related quality of life. Positive changes indicate improvement. Changes at postintervention and follow-up assessments will be compared between the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") and Sham Inductive Therapeutic Exercise (sham-ETI) groups.
Time frame: Baseline, immediately after the 8-week intervention, and approximately one month after intervention completion (approximately week 12).
Change in Multiple Sclerosis Quality of Life-54 mental health composite score
Change from baseline in the mental health composite score of the Multiple Sclerosis Quality of Life-54 questionnaire (MSQoL-54), administered using its validated Spanish version. This composite combines emotional well-being, role limitations due to emotional problems, cognitive function, health distress, and overall quality of life. It is a separate score from the physical health composite reported in Outcome Measure 11. Scores range from 0 to 100, with higher scores indicating better mental health-related quality of life. Positive changes indicate improvement. Changes at postintervention and follow-up assessments will be compared between the Inductive Therapeutic Exercise and sham intervention groups.
Time frame: Baseline, immediately after the 8-week intervention, and approximately one month after intervention completion (approximately week 12).
Adherence: number of intervention sessions completed
Number of intervention sessions completed by each participant during the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") or Sham Inductive Therapeutic Exercise (sham-ETI) program, recorded by the treating physiotherapist in the study case report form. Values range from 0 to 8 completed sessions, with higher values indicating greater adherence. Session completion will be summarized for each intervention group.
Time frame: Throughout the 8-week intervention period.
Tolerability: number of participants requiring interruption of intervention maneuvers
Number of participants with at least one intervention maneuver stopped because of excessive fatigue, intense pain, or inability to control induced neuromuscular responses during the Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") or Sham Inductive Therapeutic Exercise (sham-ETI) program. The treating physiotherapist will record each interruption and its reason in the study case report form. Each participant will be counted once for this outcome, regardless of the number of interruptions. Interruptions for unrelated logistical reasons will not be included.
Time frame: During intervention sessions throughout the 8-week treatment period.
Number of participants with intervention-related clinical incidents
Number of participants experiencing at least one clinical incident considered related to Inductive Therapeutic Exercise (ETI, from the Spanish "Ejercicio Terapéutico Inductivo") or Sham Inductive Therapeutic Exercise (sham-ETI) during the intervention or follow-up period. Incidents will be documented in the study case report form and reviewed by the principal investigator to assess their relationship to the intervention. The nature of each incident will be described. Each participant will be counted once for this outcome, regardless of the number of incidents experienced.
Time frame: From the first intervention session through the follow-up assessment approximately one month after completion of the 8-week intervention (approximately week 12).
Plan to share: No
Start is estimated for Oct 2027; primary completion for Jul 2028, 9 months later.
Of 852 non-industry interventional studies with no phase under Multiple Sclerosis, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 43. This study's planned 9 months is below that.
Counting every sponsor, half of 874 studies reached it within 21 months; a quarter within 9 and three quarters within 43.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.